April 2, 2015

A Kline industry expert pointed to the launch of Nasacort 24HR as a significant driver behind the 10% increase in allergy sales. 

March 18, 2015

Chattem on Wednesday teamed with a pair of allergy experts on the importance of smell to allergy sufferers. 

March 4, 2015

According to ECRM’s analysis of circular retail promotions for allergy, Chattem emerged as the leading advertiser of allergy remedies.

February 24, 2015

Feeding peanut-containing snacks to infants has been found to prevent peanut allergies from developing in children. 

February 18, 2015

Flonase Allergy Relief partnered with The Weather Channel to provide allergy tools and resources. 

 

February 6, 2015

GlaxoSmithKline officially launched its Flonase allergy relief onto nonprescription shelves.

January 16, 2015

A new study by Dana-Farber Cancer Institute investigators demonstrates that vitamin D can protect some people with colorectal cancer by perking up the immune system’s vigilance against tumor cells.

January 7, 2015

Pharmavite earlier this year launched a product that capitalizes on two current growth trends — immunity supplements and the gummy format. 

December 19, 2014

Teva Pharmaceutical announced that the Food and Drug Administration approved QNasl (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis in children ages 4 years to 11 years.

November 19, 2014

Nearly eight in 10 Americans (78%) would consider seeing a healthcare professional virtually for at least one healthcare need, according to a new Harris Poll.

November 17, 2014

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

November 7, 2014

Teva Pharmaceutical on Friday announced positive findings from a Phase III clinical study that examined the safety and efficacy of Qnasl.

October 16, 2014

Shara Rudner, director, clinical trials group for Restore Health, was part of a research collaboration that developed a new delivery system that could help millions of people who suffer from seasonal allergies. 

September 3, 2014

Procter & Gamble on Wednesday announced the introduction of Vicks QlearQuil, a family of over-the-counter medications for the occasional allergy sufferer. 

August 20, 2014

The allergy remedy business is growing, and not just because of new entries to the market like Chattem’s Nasacort 24HR, which to date has brought in more than $50 million to the category. Allergy seasons are lasting longer, and there are more people suffering from allergies.

August 20, 2014

Reckitt Benckiser recently extended its Mucinex brand into the allergy set with the appropriately named Mucinex Allergy.

August 20, 2014

Researchers at the University of California, San Diego School of Medicine concluded that aspirin, in addition to preventing pain and inflammation, actually helps hasten the end of inflammation in a study published this week in the online early edition of PNAS.

August 6, 2014

The National Advertising Division on Wednesday determined that Chattem can support certain advertising claims for “Nasacort Allergy 24HR,” an over-the-counter allergy relief medication. The claims were challenged by Merck Consumer Care.

June 18, 2014

The U.S. Global Research Program in May issued an 800-page National Climate Assessment report that does not bode well for the more than 50 million Americans with allergies and asthma — their already terrible symptoms are about to get worse.

June 18, 2014

With the ragweed season getting longer and longer, according to government reports, allergy has become a significant driver behind trips to the eye care aisle, and represents a much broader potential patient base. In response to rising temperatures, ragweed pollen season length increased between 1995 and 2011 by as much as 11 days (to 27 days) in parts of the United States and Canada.

June 18, 2014

The need state for allergy remedies is significant, according to documents filed by Merck recently in support of its application to switch Singulair. Allergies represent the fifth most-common chronic disease in the United States, impacting 1-in-5 Americans. As many as 90% of allergy sufferers self-treat their condition, and 58% only use an OTC or herbal remedy to relieve their allergy symptoms.

May 27, 2014

Allergy season is at full strength, and it already seems to be one for the record books. Many patients are turning to their pharmacist to ask about the symptoms they are experiencing and why they feel so much worse than in years past. The answer — simple to some and hard to believe for others — is climate change.